MYM

Rogers $1M Season of Canada’s Got Talent: Top Performances from Tonight’s Episode on Citytv

Retrieved on: 
Wednesday, March 20, 2024
CIBC, MAT, AB, Carbonear, Talent (measurement), Kardinal Offishall, MYM, CGT, Lilly, Queen, Film industry

– Rogers is giving this year’s winner $1M, the largest cash prize in Canadian television history –

Key Points: 
  • – Rogers is giving this year’s winner $1M, the largest cash prize in Canadian television history –
    – Catch up on tonight’s episode of Canada’s Got Talent on-demand or stream on Citytv+.
  • Singer MATTHEW COOPER’s (Carbonear, NL) performance of “Who Wants To Live Forever” by Queen, brought all four judges to their feet.
  • 4-year-old YUVIN MARASINI (Ajax, ON) – the youngest contestant to grace the CGT stage – performed an adorable cover of “Vacation” by Dirty Heads.
  • Together with Canada’s Got Talent, Rogers is committed to investing in premium original Canadian content while fostering homegrown talent.

IM Cannabis to Report Second Quarter 2022 Financial Results on Monday, August 15 at 9:00am ET

Retrieved on: 
Thursday, August 4, 2022
Quality control, Cannabis, MYM, Patient, Company, CSE, Pharmacy, Ecosystem, TJAC, NASDAQ, Growth, Drug

(the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the second quarter ended June 30, 2022, on Monday, August 15, 2022 before market opens.

Key Points: 
  • (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, will report operational and financial results for the second quarter ended June 30, 2022, on Monday, August 15, 2022 before market opens.
  • IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • IM Cannabis is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal markets.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it also distributes cannabis to pharmacies to medical cannabis patients.

Mexico’s Traxión Will Save 1,580 Metric Tons of Emissions and USD2.5M in Costs Once Transport Operations Are Fully Optimized Using FICO Platform

Retrieved on: 
Thursday, May 12, 2022
Other Transport, Environment, Trucking, Automotive, Transport, Alternative Energy, Energy, Logistics, Supply Chain Management, Fleet Management, Mexican Stock Exchange, Biophysical environment, Fraud, Air conditioning, FICO, Euclidean distance, LIPU, Telecommunication, Goal, AFN, Solution, Transport, USD, Â, COVID-19, Thought, Efficiency, Industry, MYM, Conference, Border, Technology, Travel, Organization, Auto Express, Heart, Growth, NYSE, ESG, Tobacco, Taxicab, Fertilizer

The company has already saved 2.9 million kilometers in travel, USD$725,000 in costs and 458 metric tons of emissions after implementing just 11% of the optimal solution.

Key Points: 
  • The company has already saved 2.9 million kilometers in travel, USD$725,000 in costs and 458 metric tons of emissions after implementing just 11% of the optimal solution.
  • Traxin is on track to reduce empty trips by 20 percent which will save it over 10 million kilometers, USD$2.5M in costs and an impressive 1,580 metric tons of emissions once its operations are fully optimized.
  • In addition, the spreadsheet macros were often difficult to use, and did not allow for easy integration of new rules and constraints.
  • The advances in optimization are also contributing significantly to Traxins emissions reductions, with 458 metric tons of emissions saved after implementing just 11% of the optimal solution and 1,580 metric tons of emissions expected once its operations are fully optimized.

IM Cannabis to Report First Quarter 2022 Financial Results on Thursday, May 12 at 5:00 p.m. ET

Retrieved on: 
Thursday, May 5, 2022
Ecosystem, NASDAQ, Cannabis, Company, Patient, CSE, MYM, Pharmacy, Quality control, TJAC, Growth, Drug

A recording of the conference call will also be available on the events & presentations section of the IM Cannabis investor relations website linked here .

Key Points: 
  • A recording of the conference call will also be available on the events & presentations section of the IM Cannabis investor relations website linked here .
  • IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • IM Cannabis is one of the very few companies with operations in Israel, Germany and Canada, the three largest federally legal markets.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it also distributes cannabis to pharmacies to medical cannabis patients.

IM Cannabis Strengthens Focus on Importing Premium and Ultra-Premium Products from its Canadian Subsidiaries

Retrieved on: 
Wednesday, April 6, 2022
Company, Pharmacy, Quality control, NASDAQ, Sale, IMC, Forward-looking statement, Growth, SEDAR, Risk, Disease, Line of credit, Cannabis, TJAC, Industry, Ecosystem, IFRS, Sdei Avraham, COVID-19, MYM, Credit, Efficiency, Patient, IFRS 10, CSE, Drug

TORONTO, Canada and GLIL YAM, Israel , April 6, 2022 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, today announced new strategic imperatives designed to enhance organizational efficiency and reduce operating costs while further responding to the increased demand for premium, indoor-grown Canadian cannabis from Israeli consumers. As part of these changes, Focus Medical Herbs Ltd. ("Focus Medical") has decided to close the Sde Avraham cultivation farm in Israel that it owns and operates. Focus Medical has an exclusive commercial agreement with IM Cannabis to distribute its production under the IMC brand. Focus Medical will complete the closure of the Sde Avraham cultivation farm during the second quarter of 2022.

Key Points: 
  • Focus Medical has an exclusive commercial agreement with IM Cannabis to distribute its production under the IMC brand.
  • "IM Cannabis is well positioned to meet the elevated demand for premium cannabis through our global supply chain and cultivation facilities in Canada," said Oren Shuster, Chief Executive Officer of IM Cannabis.
  • IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH, where it also distributes cannabis to pharmacies to medical cannabis patients.

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Retrieved on: 
Tuesday, February 8, 2022
NASDAQ, MACOM Technology Solutions, Industry, Forward-looking statement, Growth, Canadian Securities Exchange, MYM, SEDAR, Public opinion, CSE, Social media, Awareness, Technology, Trichome, IPO, COVID-19, Company, Perception, Cannabis, City, Agreement, Good, IFRS, Patient, TJAC, ESG, Pharmacy, Disease, Quality control, USD, SPAC, Tax, Public relations, Movement, IFRS 10, Ecosystem, Brooks, MZ, Risk, Drug, Pharmaceutical industry

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.

Key Points: 
  • TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.
  • IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH ("Adjupharm"), where it also distributes cannabis to pharmacies to medical cannabis patients.
  • MZ North America is the US division of MZ Group, a global investor relations and corporate communications leader.

IM Cannabis Engages MZ Group to Lead Strategic Investor Relations and Shareholder Communications Program

Retrieved on: 
Tuesday, February 8, 2022
NASDAQ, MACOM Technology Solutions, Industry, Forward-looking statement, Growth, Canadian Securities Exchange, MYM, SEDAR, Public opinion, CSE, Social media, Awareness, Technology, Trichome, IPO, COVID-19, Company, Perception, Cannabis, City, Agreement, Good, IFRS, Patient, TJAC, ESG, Pharmacy, Disease, Quality control, USD, SPAC, Tax, Public relations, Movement, IFRS 10, Ecosystem, Brooks, MZ, Risk, Drug, Pharmaceutical industry

TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.

Key Points: 
  • TORONTO, ON and GLIL YAM, Israel, Feb. 8, 2022 /PRNewswire/ -- IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) ("IM Cannabis" or the "Company"), a leading medical and adult-use recreational cannabis company with operations in Israel, Canada, and Germany, has engaged international investor relations specialists MZ Group ("MZ") to lead the Company's strategic investor relations and financial communications program across all key markets.
  • IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading international cannabis company providing premium products to medical patients and adult-use recreational consumers.
  • In Germany, the IM Cannabis ecosystem operates through Adjupharm GmbH ("Adjupharm"), where it also distributes cannabis to pharmacies to medical cannabis patients.
  • MZ North America is the US division of MZ Group, a global investor relations and corporate communications leader.